Candidiasis – Pipeline Review, Demonstrate Growth, Pharmaceuticals, Experiments, Research, Analysis, Evolutions H1 2019

Posted on 2019-04-02 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2019-Apr-02 — /EPR Network/ —This research study added to the broad database of Market Research Hub (MRH) focusing on the Candidiasis – Pipeline Review, H1 2019 delivers an in-depth outlook to present information about executive summary and key performance indicators. Furthermore, readers can gather knowledge about the economic status, demographics and competitive landscape which is prevailing in the concerned industry during the review period, 2019. Overall, the purpose of this assessment is to present a clear picture highlighting the transformations expected to occur in the Candidiasis driven by major trends and opportunities.

Get Sample Copy of This Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2197331

Candidiasis – Pipeline Review, H1 2019

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis – Pipeline Review, H1 2019, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.

Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin, the folds of the buttocks, between the breasts, toes, or fingers, and in the navel. Treatment includes antifungal drugs.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Candidiasis – Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Candidiasis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Candidiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Candidiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 4, 5, 2, 26, 7 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 11 and 10 molecules, respectively.

Candidiasis (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Candidiasis (Infectious Disease).
– The pipeline guide reviews pipeline therapeutics for Candidiasis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Candidiasis (Infectious Disease) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Candidiasis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Candidiasis (Infectious Disease)

BROWSE Full Report NOW @ https://www.marketresearchhub.com/report/candidiasis-pipeline-review-h1-2019-report.html

Table of Contents

Introduction
Candidiasis – Overview
Candidiasis – Therapeutics Development
Candidiasis – Therapeutics Assessment
Candidiasis – Companies Involved in Therapeutics Development
Candidiasis – Drug Profiles
Candidiasis – Dormant Projects
Candidiasis – Discontinued Products
Candidiasis – Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Candidiasis, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Universities/Institutes, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Candidiasis – Pipeline by Amplyx Pharmaceuticals Inc, H1 2019
Candidiasis – Pipeline by APEIRON Biologics AG, H1 2019
Candidiasis – Pipeline by Bakker Medical Srl, H1 2019
Candidiasis – Pipeline by Beta Pharma Inc, H1 2019
Candidiasis – Pipeline by Biosergen AS, H1 2019

More Information………@@@

Enquire about this Report @ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2197331

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Healthcare market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick